Correction: Safety and effectiveness of intravenous abatacept for polyarticular-course juvenile idiopathic arthritis: An all-case postmarketing surveillance study.

Authors: Nozawa, Tomo¹ (AUTHOR) tnozawa@yokohama-cu.ac.jp, Iwata, Naomi² (AUTHOR), Igarashi, Toru³ (AUTHOR), Kobayashi, Ichiro⁴ (AUTHOR), Ota, Shoji⁵ (AUTHOR), Yamada, Takako⁵ (AUTHOR), Bando, Etsuya⁵ (AUTHOR), Habiro, Katsuyoshi⁵ (AUTHOR), Takei, Syuji⁶ (AUTHOR)

Source: Pediatric Rheumatology. 3/12/2025, Vol. 23 Issue 1, p1-3. 3p.

Subject Terms: *JUVENILE idiopathic arthritis, *ABATACEPT, *ENCODING

How to improve translatability and clinical relevance of preclinical studies in rheumatoid arthritis.

Authors: Kalliolias, George D.^1,2,3 (AUTHOR), Basdra, Efthimia K.⁴ (AUTHOR), Papavassiliou, Athanasios G.⁴ (AUTHOR) papavas@med.uoa.gr

Source: Immunology. Mar2024, Vol. 171 Issue 3, p440-443. 4p.

Subject Terms: *RHEUMATOID arthritis, *ABATACEPT, *EXPERIMENTAL arthritis, *TUMOR necrosis factors

AZD9567 versus prednisolone in patients with active rheumatoid arthritis: A phase IIa, randomized, double‐blind, efficacy, and safety study.

Authors: van Laar, Jacob M.¹ (AUTHOR) j.m.vanlaar@umcutrecht.nl, Lei, Alejhandra² (AUTHOR), Safy‐Khan, Mary¹ (AUTHOR), Almquist, Joachim³ (AUTHOR), Belfield, Graham⁴ (AUTHOR), Edman, Karl⁵ (AUTHOR), Öberg, Lisa⁶ (AUTHOR), Angermann, Bastian R.⁶ (AUTHOR), Dillmann, Inken⁴ (AUTHOR), Berntsson, Pia⁷ (AUTHOR), Etal, Damla⁴ (AUTHOR), Dainty, Ian⁷ (AUTHOR), Astbury, Carol⁸ (AUTHOR), Belvisi, Maria G.^9,10 (AUTHOR), Nemes, Szilárd¹¹ (AUTHOR), Platt, Adam¹² (AUTHOR), Prothon, Susanne³ (AUTHOR), Samuelsson, Sara¹³ (AUTHOR), Svanberg, Petter¹⁴ (AUTHOR), Keen, Christina¹³ (AUTHOR)

Source: CTS: Clinical & Translational Science. Dec2023, Vol. 16 Issue 12, p2494-2506. 13p.

Subject Terms: *PREDNISOLONE, *ABATACEPT, *RHEUMATOID arthritis, *MINERALOCORTICOID receptors, *WATER-electrolyte balance (Physiology), *GLUCOCORTICOID receptors

CD39 expression on immune cells predicts methotrexate response in rheumatoid arthritis patients.

Authors: BORAL, Barış¹ boralbaris@gmail.com, TUNCER, İbrahim², KİBAR, Filiz³, ÇETİNER, Salih⁴, BADAK, Suade Özlem⁵, SALMAN, Emrah⁶, KOÇ, Emrah⁷, ERKEN, Eren⁷, YAMAN, Akgün¹

Source: Turkish Journal of Medical Sciences. 2023, Vol. 53 Issue 5, p1075-1083. 9p.

Subject Terms: *ABATACEPT, *RHEUMATOID arthritis, *MYELOID-derived suppressor cells, *JOINTS (Anatomy), *METHOTREXATE, *T cells

Erfolgreiche Behandlung eines Patienten mit therapierefraktärer rheumatoider Arthritis-assoziierter interstitieller Lungenerkrankung mit Upadacitinib: ein Fallbericht.

Authors: Nishii, Yuuya^1,2 (AUTHOR), Okamoto, Masaki^1,2 (AUTHOR), Zaizen, Yoshiaki² (AUTHOR), Kojima, Takashi^1,2 (AUTHOR), Nouno, Takashi^1,2 (AUTHOR), Naitou-Nishida, Yoshiko^1,2 (AUTHOR), Matsuo, Norikazu^1,2 (AUTHOR), Takeoka, Hiroaki^1,2 (AUTHOR), Ishida, Motoko³ (AUTHOR), Nakamura, Masataka³ (AUTHOR), Masuda, Toru³ (AUTHOR), Tanaka, Takafumi³ (AUTHOR), Miyamura, Tomoya³ (AUTHOR), Hoshino, Tomoaki² (AUTHOR)

Source: Kompass Autoimmun. 2025, Vol. 7 Issue 1, p44-49. 6p.

Subject Terms: *TACROLIMUS, *ABATACEPT, *ARTHRITIS, *PROTEINS

Hunting uncertainties: JAK inhibitors and cancer risk.

Authors: Lee, Hsiu‐Ming¹ (AUTHOR), Chi, Huan‐Ting² (AUTHOR), Wei, James Cheng‐Chung^3,4,5,6 (AUTHOR) jccwei@gmail.com

Source: International Journal of Rheumatic Diseases. Feb2024, Vol. 27 Issue 2, p1-3. 3p.

Subject Terms: *DISEASE risk factors, *ABATACEPT, *RHEUMATOID arthritis, *SKIN cancer, *ADALIMUMAB, *MEDICAL personnel, *INFLAMMATORY bowel diseases, *CLINICAL trials, *PSORIATIC arthritis

Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial.

Authors: Rech, Juergen^1,2 (AUTHOR), Tascilar, Koray^1,2 (AUTHOR), Hagen, Melanie^1,2 (AUTHOR), Kleyer, Arnd^1,2 (AUTHOR), Manger, Bernhard^1,2 (AUTHOR), Schoenau, Verena^1,2 (AUTHOR), Hueber, Axel J^1,3,4 (AUTHOR), Kleinert, Stefan⁵ (AUTHOR), Baraliakos, Xenofon^6,7 (AUTHOR), Braun, Jürgen^6,7 (AUTHOR), Kiltz, Uta^6,7 (AUTHOR), Fleck, Martin⁸ (AUTHOR), Rubbert-Roth, Andrea⁹ (AUTHOR), Kofler, David M¹⁰ (AUTHOR), Behrens, Frank¹¹ (AUTHOR), Feuchtenberger, Martin¹² (AUTHOR), Zaenker, Michael¹³ (AUTHOR), Voll, Reinhard¹⁴ (AUTHOR), Venhoff, Nils¹⁴ (AUTHOR), Thiel, Jens^14,15 (AUTHOR)

Source: Lancet. Mar2024, Vol. 403 Issue 10429, p850-859. 10p.

Subject Terms: *Community centers, Rheumatoid arthritis, Abatacept, Joint pain, Tenosynovitis, Inflammation, Synovitis

Cost-consequence of abatacept as first-line therapy in Japanese rheumatoid arthritis patients using IORRA real-world data.

Authors: Tanaka, Eiichi^1,2 (AUTHOR) e-tanaka@twmu.ac.jp, Inoue, Eisuke^1,3 (AUTHOR), Shoji, Ayako⁴ (AUTHOR), Nilsson, Jonas⁵ (AUTHOR), Papagiannopoulos, Christos⁵ (AUTHOR), Dhanda, Devender⁶ (AUTHOR), Yoshizawa, Yuri⁷ (AUTHOR), Abe, Mai^1,2 (AUTHOR), Saka, Kumiko^1,2 (AUTHOR), Sugano, Eri^1,2 (AUTHOR), Sugitani, Naohiro^1,2 (AUTHOR), Ochiai, Moeko^1,2 (AUTHOR), Yamaguchi, Rei^1,2 (AUTHOR), Ikari, Katsunori⁸ (AUTHOR), Yamanaka, Hisashi^1,9,10 (AUTHOR), Harigai, Masayoshi^1,2 (AUTHOR)

Source: PLoS ONE. 11/16/2022, Vol. 17 Issue 11, p1-17. 17p.

Subject Terms: *PROPENSITY score matching, *ABATACEPT, *RHEUMATOID arthritis, *JAPANESE yen, *DISEASE duration, *MEDICAL care costs, *TIME perspective

Combination of Methotrexate and Leflunomide Is Efficient and Safe for 60 Patients with Rheumatoid Arthritis.

Authors: Chen, Fang¹ (AUTHOR), Wang, Yingfang¹ (AUTHOR), Wang, Liuqing¹ (AUTHOR), Du, Hongwei¹ (AUTHOR), He, Shan¹ (AUTHOR)

Source: Computational & Mathematical Methods in Medicine. 10/3/2022, p1-6. 6p.

Subject Terms: *RHEUMATOID arthritis, *ABATACEPT, *PATIENT safety, *JOINT pain, *RHEUMATOID arthritis diagnosis, *BLOOD sedimentation, *ANTIRHEUMATIC agents

Comparing the effectiveness and safety of Abatacept and Tocilizumab in elderly patients with rheumatoid arthritis.

Authors: Temmoku, Jumpei¹ (AUTHOR), Miyata, Masayuki² (AUTHOR), Suzuki, Eiji³ (AUTHOR), Sumichika, Yuya¹ (AUTHOR), Saito, Kenji¹ (AUTHOR), Yoshida, Shuhei¹ (AUTHOR), Matsumoto, Haruki¹ (AUTHOR), Fujita, Yuya¹ (AUTHOR), Matsuoka, Naoki¹ (AUTHOR), Asano, Tomoyuki¹ (AUTHOR), Sato, Shuzo¹ (AUTHOR), Watanabe, Hiroshi¹ (AUTHOR), Migita, Kiyoshi¹ (AUTHOR) migita@fmu.ac.jp

Source: PLoS ONE. 9/19/2022, Vol. 17 Issue 9, p1-17. 17p.

Subject Terms: *ABATACEPT, *OLDER patients, *RHEUMATOID arthritis, *INTERSTITIAL lung diseases, *TOCILIZUMAB, *DEMOGRAPHIC characteristics

Company/Entity: AMERICAN Ballet Theatre

Abatacept retention and clinical effectiveness in patients with rheumatoid arthritis in a real‐world setting in Taiwan.

Authors: Chen, Kun‐Hung¹ (AUTHOR), Li, Ko‐Jen² (AUTHOR), Fang, Yao‐Fan³ (AUTHOR), Hsieh, Song‐Chou² (AUTHOR), Chen, Ying‐Chou⁴ (AUTHOR), Lee, Chyou‐Shen⁵ (AUTHOR), Luo, Shue‐Fen³ (AUTHOR), Cheng, Tien‐Tsai⁴ (AUTHOR), Tsai, Wen Chan⁶ (AUTHOR), Lo, Yu‐Chen⁷ (AUTHOR), Lan, Joung‐Liang⁸ (AUTHOR) jounglan@me.com

Source: International Journal of Rheumatic Diseases. Jul2024, Vol. 27 Issue 7, p1-13. 13p.

Subject Terms: *ABATACEPT, *ANTIRHEUMATIC agents

Geographic Terms: TAIWAN

Emerging Immunotherapies for Disease Modification of Type 1 Diabetes: Emerging Immunotherapies for Disease Modification of T1DM: T. P. Foster et al.

Authors: Foster, Timothy P., Bruggeman, Brittany S., Haller, Michael J.

Source: Drugs; Apr2025, Vol. 85 Issue 4, p457-473, 17p

Subject Terms: INSULIN therapy, THERAPEUTIC use of monoclonal antibodies, TYPE 1 diabetes, ANTILYMPHOCYTIC serum, IMMUNOTHERAPY, ABATACEPT, RITUXIMAB, CELLULAR therapy, JANUS kinases, GLUTAMIC acid, AUTOIMMUNE diseases, NEUROTRANSMITTER uptake inhibitors, CYTOKINES, TUMOR necrosis factors

Anti-pentraxin 3 antibodies and residual disease activity in rheumatoid arthritis.

Authors: Salvato, Mariangela, Frizzera, Francesca, Ghirardello, Anna, Calligaro, Antonia, Botsios, Costantino, Zen, Margherita, Doria, Andrea, Giollo, Alessandro

Source: Rheumatology; Apr2025, Vol. 64 Issue 4, p1672-1678, 7p

Subject Terms: CROSS-sectional method, BODY mass index, AUTOANTIBODIES, RHEUMATOID arthritis, ENZYME-linked immunosorbent assay, SEX distribution, BODY weight, SMOKING, FISHER exact test, SEVERITY of illness index, PREDNISONE, ABATACEPT, AGE distribution, MANN Whitney U Test, MULTIVARIATE analysis, STATURE, RESEARCH, ANALYSIS of variance, HEALTH outcome assessment, COMPARATIVE studies, TOCILIZUMAB, SOCIODEMOGRAPHIC factors, DATA analysis software, INFLAMMATION, TUMOR necrosis factors, RHEUMATOLOGISTS, GLUCOCORTICOIDS, REGRESSION analysis

Abatacept, Golimumab, and Sarilumab as Selected Bio-Originator Disease-Modifying Antirheumatic Drugs with Diverse Mechanisms of Action in Their Current Use in Treatment.

Authors: Kawczak, Piotr, Feszak, Igor Jarosław, Bączek, Tomasz

Source: Journal of Clinical Medicine; Mar2025, Vol. 14 Issue 6, p2107, 22p

Subject Terms: ANTIRHEUMATIC agents, RHEUMATOID arthritis, ABATACEPT, OSTEOARTHRITIS, GOUT

Rheumatoid factors revisited in the age of biologic therapy.

Authors: Avci, Ali Berkant, Feist, Eugen, Burmester, Gerd R

Source: Rheumatology; 2025 Supplement, pii15-ii24, 10p

Subject Terms: THERAPEUTIC use of monoclonal antibodies, ANTI-inflammatory agents, AUTOANTIBODIES, RHEUMATOID arthritis, ANTIRHEUMATIC agents, RITUXIMAB, ABATACEPT, BIOTHERAPY, DRUG efficacy, INDIVIDUALIZED medicine, TOCILIZUMAB

Highlights from the plenary session: advances in treatment (I).

Authors: Smith, Rona M, Hellmich, Bernhard

Source: Rheumatology; 2025 Supplement, Vol. 64, pi88-i91, 4p

Subject Terms: VASCULITIS, IMMUNIZATION, ANTINEUTROPHIL cytoplasmic antibodies, CLINICAL trials, CONFERENCES & conventions, ABATACEPT, DISEASE remission, GRANULOMATOSIS with polyangiitis, PLASMA exchange (Therapeutics), GLUCOCORTICOIDS

Immune Checkpoints and the Immunology of Liver Fibrosis.

Authors: Tsomidis, Ioannis, Voumvouraki, Argyro, Kouroumalis, Elias

Source: Livers; Mar2025, Vol. 5 Issue 1, p5, 58p

Subject Terms: CIRRHOSIS of the liver, MACROPHAGES, T cells, ABATACEPT, IMMUNE checkpoint inhibitors, PROTEOMICS, PROGRAMMED cell death 1 receptors, CYTOKINES

Effectiveness of JAK Inhibitors Compared With Biologic Disease‐Modifying Antirheumatic Drugs on Pain Reduction in Rheumatoid Arthritis: Results From a Nationwide Swedish Cohort Study.

Authors: Eberhard, Anna, Di Giuseppe, Daniela, Askling, Johan, Bergman, Stefan, Bower, Hannah, Chatzidionysiou, Katerina, Forsblad‐d'Elia, Helena, Kastbom, Alf, Olofsson, Tor, Frisell, Thomas, Turesson, Carl

Source: Arthritis & Rheumatology; Mar2025, Vol. 77 Issue 3, p253-262, 10p

Subject Terms: BIOTHERAPY, ANTI-inflammatory agents, RESEARCH funding, RHEUMATOID arthritis, VISUAL analog scale, MULTIPLE regression analysis, ANTIRHEUMATIC agents, TREATMENT effectiveness, RETROSPECTIVE studies, ABATACEPT, RITUXIMAB, MULTIVARIATE analysis, DESCRIPTIVE statistics, JANUS kinases, LONGITUDINAL method, PAIN management, MEDICAL records, ACQUISITION of data, NEUROTRANSMITTER uptake inhibitors, COMPARATIVE studies, CONFIDENCE intervals, DATA analysis software, INTERLEUKINS, COMORBIDITY, CHEMICAL inhibitors

Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial.

Authors: Cope, Andrew P¹, andrew.cope@kcl.ac.uk, Jasenecova, Marianna¹, Vasconcelos, Joana C², Filer, Andrew³, Raza, Karim³, Qureshi, Sumera¹, D'Agostino, Maria Antonietta⁴, McInnes, Iain B⁵, Isaacs, John D⁶, Pratt, Arthur G⁶, Fisher, Benjamin A³, Buckley, Christopher D⁷, Emery, Paul⁸, Ho, Pauline⁹, Buch, Maya H⁹, Ciurtin, Coziana¹⁰, van Schaardenburg, Dirkjan¹¹, Huizinga, Thomas¹², Toes, René¹², Georgiou, Evangelos¹³

Source: Lancet; Mar2024, Vol. 403 Issue 10429, p838-849, 12p

Mycosis fungoides‐like eruptions associated with abatacept.

Authors: Hoshina, Daichi¹ (AUTHOR) hoshinad@gmail.com, Nagata, Yuri¹ (AUTHOR)

Source: Australasian Journal of Dermatology. May2024, Vol. 65 Issue 3, pe77-e78. 2p.

Subject Terms: *ABATACEPT, *MYCOSES, *HUMAN cloning, *ASSOCIATION of ideas, *MYCOSIS fungoides, *PARACOCCIDIOIDOMYCOSIS, *T cells